Methotrexate vs Ustekinumab
Methotrexate vs Ustekinumab: Overview
This comparison examines the pharmacological differences between Methotrexate and Ustekinumab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5.
Molecular Weight: Methotrexate — 454.4400 g/mol.
Type: Methotrexate — Small molecule; Ustekinumab — Antibody.